New Missions for an Old Agent: Granulocyte-Colony Stimulating Factor in the Treatment of Stroke Patients
2015
Granulocyte-colony stimulating factor (G-CSF) has a multimodal neuroprotective profile
and the cumulative preclinical data from numerous translational studies statistically confirmed the efficacy
of G-CSF as a treatment option in ischemic stroke. G-CSF activates anti-apoptotic, antioxidative,
and anti-inflammatory signaling pathways and stimulates angiogenesis and neurogenesis. In
this review, we summarize the role of G-CSF and the corresponding signal transduction pathways
regulated by G-CSF in neuroprotection and discuss its potential as a new drug for stroke treatment.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
5
Citations
NaN
KQI